Lawrence Wexler - 26 Dec 2025 Form 4 Insider Report for Turning Point Brands, Inc. (TPB)

Role
Director
Signature
/s/ Lawrence Wexler
Issuer symbol
TPB
Transactions as of
26 Dec 2025
Net transactions value
$0
Form type
4
Filing time
04 Mar 2026, 21:56:37 UTC
Previous filing
13 Nov 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wexler Lawrence Director 5201 INTERCHANGE WAY, LOUISVILLE /s/ Lawrence Wexler 04 Mar 2026 0001660246

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPB Common Stock Gift -2,800 -0.99% $0.000000* 280,491 26 Dec 2025 Direct F1, F2
transaction TPB Common Stock Award +8,369 +3% $108.51* 288,860 02 Mar 2026 Direct F3
transaction TPB Common Stock Award +927 +0.32% $108.51* 289,787 02 Mar 2026 Direct F4
transaction TPB Common Stock Tax liability -3,393 -1.2% $100.14* 286,394 02 Mar 2026 Direct F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TPB Options 15,900 26 Dec 2025 Common Stock 15,900 $51.75 Direct F7, F10
holding TPB Options 20,000 26 Dec 2025 Common Stock 20,000 $14.85 Direct F7, F9
holding TPB Options 35,500 26 Dec 2025 Common Stock 35,500 $47.58 Direct F7, F11
holding TPB Options 26,500 26 Dec 2025 Common Stock 26,500 $21.21 Direct F7, F12
holding TPB Options 16,819 26 Dec 2025 Common Stock 16,819 $15.41 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reports the donation of 2,800 shares of common stock to a donor advised fund.
F2 The total reported in Column 5 includes 2,205 restricted stock units and 278,286 shares of common stock.
F3 Reports common stock issued upon settlement of performance restricted units granted to the reporting person in February 2021. The compensation committee of the Board of Directors determined that the performance criteria were met on March 2, 2026. The total reported in Column 5 includes 2,205 restricted stock units and 286,655 shares of common stock.
F4 Reports common stock issued upon settlement of performance restricted units granted to the reporting person in March 2022. The compensation committee of the Board of Directors determined that the performance criteria were met on March 2, 2026. The total reported in Column 5 includes 2,205 restricted stock units and 287,582 shares of common stock.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.87 - $101.97.
F6 The total reported in Column 5 includes 2,205 restricted stock units and 284,189 shares of common stock.
F7 Granted pursuant to the issuer's 2015 Equity Incentive Plan.
F8 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2018, 33% of the underlying shares on January 1, 2019 and 33% of the underlying shares on January 1, 2020.
F9 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022 and 33% of the underlying shares on January 1, 2023.
F10 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023 and 33% of the underlying shares on January 1, 2024.
F11 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022.
F12 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021.